How many acquisitions has Novartis made so far?

Novartis has completed 44 acquisitions so far, with an average acquisition amount of $2.78B.

Which countries does Novartis usually acquire in?

Novartis has made acquisitions in 7 countries with the most activity in United States and United Kingdom.

Which is Novartis' latest acquisition?

Novartis's most recent acquisition is Myricx Bio, a Developer of antibody drug conjugates for the treatment of cancer, acquired in July 2026.

Which sectors does Novartis target for acquisitions?

Most of Novartis's acquisitions are in Oncology (11) and Immunotherapy (9).

In which year did Novartis make the most acquisitions?

Novartis was most active in 2024, with 5 acquisitions completed in that year.

List of 44 Acquisitions by Novartis (Nov 2026)

Novartis has made a total of 44 acquisitions. It has completed these transactions across 25 sectors, including Oncology, Immunotherapy, and Ophthalmology, spanning 7 countries such as United States, United Kingdom, and Switzerland. Peak activity occurred in 2024 and 2016 with 5 acquisitions each, followed by 4 in 2025. The average number of acquisitions per year for the 2020–2025 period is 2.8, and 2 acquisitions have been completed as of the current calendar year. The most recent acquisition is Myricx Bio, a London-based developer of antibody drug conjugates for cancer treatment, founded in 2019 and acquired in July 2026.

Here's the year on year acquisition history of Novartis:

Number of Total Acquisitions

Year	# Acquisitions
2026	2
2025	4
2024	5
2023	2
2022	1
2021	2
2020	3
2019	1
2018	2
2017	1
2016	5
2015	2
2014	1
2012	1
2011	1
2010	1
2009	2
2008	2
2006	2
2005	2
2002	1
1997	1

View all Acquisitions by Novartis

Recent acquisitions by Novartis

Novartis's most recent acquisition - Myricx Bio is a Developer of antibody drug conjugates for the treatment of cancer, founded in 2019 and located in London. Novartis acquired it in July 2026 for a price of $*****.

Here is the list of all acquisitions by Novartis sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Jul 06, 2026	Myricx Bio	ddew	qdaw	46	908
Mar 27, 2026	Excellergy	inqc	fcvl	13	646
Oct 27, 2025	Avidity Biosciences	knhl	mhw{	82	700
Sep 09, 2025	Tourmaline Bio	cjno	flzo	48	540
Apr 30, 2025	Regulus Therapeutics	yirs	mwtp	57	452